These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33425930)

  • 41. EQ-5D versus SF-12 in coronary patients: are they interchangeable?
    De Smedt D; Clays E; Annemans L; De Bacquer D
    Value Health; 2014; 17(1):84-9. PubMed ID: 24438721
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quality of Life and General Health After Elective Surgery for Cervical Spine Pathologies: Determining a Valid and Responsive Metric of Health State Utility.
    Chotai S; Parker SL; Sivaganesan A; Godil SS; McGirt MJ; Devin CJ
    Neurosurgery; 2015 Oct; 77(4):553-60; discussion 560. PubMed ID: 26191977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality of Life in Patients Undergoing Spine Surgery: Systematic Review and Meta-Analysis.
    Nayak NR; Stephen JH; Piazza MA; Obayemi AA; Stein SC; Malhotra NR
    Global Spine J; 2019 Feb; 9(1):67-76. PubMed ID: 30775211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discordance in Utility Measurement in Persons with Neurological Conditions: A Comparison of the SF-6D and the HUI3.
    Abel H; Kephart G; Packer T; Warner G
    Value Health; 2017 Sep; 20(8):1157-1165. PubMed ID: 28964449
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of cost-utility ratios: results across five trial-based cost-utility studies.
    Joore M; Brunenberg D; Nelemans P; Wouters E; Kuijpers P; Honig A; Willems D; de Leeuw P; Severens J; Boonen A
    Value Health; 2010; 13(2):222-9. PubMed ID: 19878492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mapping from disease-specific measures to utility: an analysis of the relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's disease and measures of utility.
    Buxton MJ; Lacey LA; Feagan BG; Niecko T; Miller DW; Townsend RJ
    Value Health; 2007; 10(3):214-20. PubMed ID: 17532814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Responsiveness of EQ-5D and SF-6D in patients with early arthritis: results from the ESPOIR cohort.
    Gaujoux-Viala C; Rat AC; Guillemin F; Flipo RM; Fardellone P; Bourgeois P; Fautrel B
    Ann Rheum Dis; 2012 Sep; 71(9):1478-83. PubMed ID: 22419775
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D.
    Sach TH; Barton GR; Doherty M; Muir KR; Jenkinson C; Avery AJ
    Int J Obes (Lond); 2007 Jan; 31(1):189-96. PubMed ID: 16682976
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of EQ-5D and SF-6D utilities in Pompe disease.
    Kanters TA; Redekop WK; Kruijshaar ME; van der Ploeg AT; Rutten-van Mölken MP; Hakkaart L
    Qual Life Res; 2015 Apr; 24(4):837-44. PubMed ID: 25342117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of the measurement properties and estimation of minimal important differences of the EQ-5D and SF-6D utility measures in patients with systemic sclerosis.
    Kwakkenbos L; Fransen J; Vonk MC; Becker ES; Jeurissen M; van den Hoogen FH; van den Ende CH
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):50-6. PubMed ID: 23910610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Health Condition Impacts in a Nationally Representative Cross-Sectional Survey Vary Substantially by Preference-Based Health Index.
    Hanmer J; Cherepanov D; Palta M; Kaplan RM; Feeny D; Fryback DG
    Med Decis Making; 2016 Feb; 36(2):264-74. PubMed ID: 26314728
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis.
    Huppertz-Hauss G; Aas E; Lie Høivik M; Langholz E; Odes S; Småstuen M; Stockbrugger R; Hoff G; Moum B; Bernklev T
    Gastroenterol Res Pract; 2016; 2016():5023973. PubMed ID: 27630711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.
    Gaujoux-Viala C; Rat AC; Guillemin F; Flipo RM; Fardellone P; Bourgeois P; Fautrel B
    J Rheumatol; 2011 Aug; 38(8):1576-84. PubMed ID: 21532054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A systematic literature review of utility weights in wet age-related macular degeneration.
    Pearson I; Rycroft C; Irving A; Ainsworth C; Wittrup-Jensen K
    J Med Econ; 2013 Nov; 16(11):1307-16. PubMed ID: 24004384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease.
    Kularatna S; Byrnes J; Chan YK; Ski CF; Carrington M; Thompson D; Stewart S; Scuffham PA
    Qual Life Res; 2017 Dec; 26(12):3399-3408. PubMed ID: 28766084
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
    Whitehurst DG; Norman R; Brazier JE; Viney R
    Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Health state utility estimates for value assessments of novel treatments in Huntington's disease: a systematic literature review.
    Sawant R; Paret K; Petrillo J; Koenig A; Wolowacz S; Ronquest N; Rickards H
    Health Qual Life Outcomes; 2024 Apr; 22(1):33. PubMed ID: 38627749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Normative Estimates and Agreement Between 2 Measures of Health-Related Quality of Life in Older People With Frailty: Findings From the Community Ageing Research 75+ Cohort.
    Nikolova S; Hulme C; West R; Pendleton N; Heaven A; Bower P; Humphrey S; Farrin A; Cundill B; Hawkins R; Clegg A
    Value Health; 2020 Aug; 23(8):1056-1062. PubMed ID: 32828218
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.